Overview
ICLR market data
Price History
ICLR price chart
Valuation & Profitability
- P/E (TTM)
- 183.55 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.90 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.25 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $66.57 – $203.91 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $12.8B · P/B 1.51 · P/S 1.53.
Company News
[Latest] Global eClinical Solutions Market Size/Share Worth USD 42.55 Billion by 2035 at a 13.98% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Globenewswire Inc · Aug 5, 2026, 11:00 AM
Citigroup Maintains Neutral on Icon, Raises Price Target to $180Benzinga · Jul 31, 2026, 8:13 PM
Truist Securities Reiterates Buy on Icon, Raises Price Target to $209Benzinga · Jul 31, 2026, 1:15 PM
ICON shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Jul 29, 2026, 8:31 PM
Icon Affirms FY2026 Adj EPS Guidance of $10.00-$11.00 vs $10.64 Est; Affirms FY2026 Sales Guidance of $7.850B-$8.150B vs $8.063B EstBenzinga · Jul 29, 2026, 8:23 PM
Icon Q2 Adj. EPS $2.56 Beats $2.52 Estimate, Sales $2.063B Beat $2.006B EstimateBenzinga · Jul 29, 2026, 8:15 PM
ICON shares are trading higher after the company announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle.Benzinga · Jul 28, 2026, 3:27 PM
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On TuesdayBenzinga · Jul 28, 2026, 2:05 PM
Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate GrowthGlobenewswire Inc · Jul 15, 2026, 11:15 AM
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in ICON plc (ICLR) to Contact Law FirmGlobenewswire Inc · Jul 9, 2026, 9:15 PM